132 large varieties of Chinese patent medicines are about to open bids

01 Registration deadline for the centralized procurement of proprietary Chinese medicines

According to the "Notice on Carrying out the Registration for the Concentrated Procurement of Chinese Patent Medicines such as Qingkailing of the Guangdong Alliance" issued by the Guangdong Provincial Drug Trading Center, the registration for the centralized procurement of the alliance has ended at 17:00 on February 15

After the relevant enterprises have completed the registration, the centralized procurement work will enter the subsequent stage of review, publicity and bid opening

The members of the Guangdong Traditional Chinese Medicine Centralized Procurement Alliance include 6 provinces including Guangdong, Shanxi, Henan, Hainan, Ningxia, Qinghai, etc.

This centralized procurement has attracted much attention because of the large number of varieties involved, the large market space, the relatively complex procurement rules, and the possibility of becoming a reference for the subsequent expansion of the centralized procurement of proprietary Chinese medicines

Procurement of proprietary Chinese medicines in bulk is difficult, mainly because the bottlenecks in two aspects are difficult to break through

One is the problem of grouping.

As the first Chinese patent medicine centralized procurement alliance to issue a draft for comments, Guangdong opened a precedent for large-scale centralized procurement of Chinese patent medicines, but Hubei Chinese patent medicine alliance took the lead in completing the whole process from document release to bid opening

The results showed that the selection rate of Hubei Chinese patent medicine centralized procurement alliance reached 62%, and the average price of the selection decreased by 42.

In terms of rules, the two major procurement alliances in Guangdong and Hubei are generally similar, but they are different in terms of product grouping, product ladder quotations and bidding rules, and their final performance remains to be seen

02 The general trend

Although there are certain difficulties, the centralized procurement of Chinese patent medicines is the general trend under the background that the procurement with volume should be collected as much as possible

Before Guangdong and Hubei organized the Procurement Alliance for Proprietary Chinese Medicine, Zhejiang Jinhua, Puyang, Qinghai and other places had conducted pilot projects of centralized procurement of Chinese patent medicines, and had some experience

The centralized procurement of Chinese patent medicines has gradually shifted from the municipal and provincial pilots to the centralized procurement of multiple inter-provincial alliances covering a wide range

On February 11, the State Council Information Office held a regular briefing on the progress of the reform of the centralized procurement of medicines and high-value medical consumables.

On January 14, the National Medical Security Work Conference will also promote local governments to actively carry out centralized procurement of medicines, improve drug price governance capabilities, and achieve an all-round promotion of the centralized procurement pattern in chemical medicines, biological medicines, and proprietary Chinese medicines, which will be listed as medical insurance work in 2022.

There are 1,374 kinds of Chinese patent medicines in the 2021 version of the medical insurance catalog, and there are about 300-500 kinds of Chinese patent medicines commonly used in hospitals

In addition to the centralized procurement of proprietary Chinese medicines, other categories in the field of traditional Chinese medicine are also covered by volume procurement

On June 30, 2021, the National Medical Insurance Administration responded for the first time to the recommendation No.
4126 of the Fourth Session of the Thirteenth National People's Congress: It will work with relevant departments on the basis of improving the quality evaluation standards for Chinese patent medicines and formula granules.
Guided by clinical needs, starting from high-priced and large-volume varieties, scientifically and prudently promote the reform of centralized procurement of Chinese patent medicines and formula granules
.

In addition, at the end of 2021, the "Guiding Opinions on Medical Insurance Supporting the Inheritance, Innovation and Development of Traditional Chinese Medicine" issued by the National Medical Insurance Administration and the State Administration of Traditional Chinese Medicine clarifies that Chinese medicine formula granules purchased by public medical institutions are encouraged to be included in the provincial centralized pharmaceutical procurement platform.
transactions, and promote open and transparent transactions
.

In fact, more and more regions have included traditional Chinese medicine formula granules into provincial procurement platforms
.
The industry believes that all localities are carrying out sunshine procurement of traditional Chinese medicine pieces and formula granules, or paving the way for their inclusion in centralized procurement
.

03 Inter-provincial purchasing alliance is the mainstream trend

In addition to the Chinese Patent Medicine Alliance, the registration for the centralized procurement of diclofenac and other drugs in the Guangdong 11-province alliance has also ended at 17:00 yesterday
.
The alliance area includes 11 provinces including Guangdong, Shanxi, Jiangxi, Henan, Guangxi, Hainan, Guizhou, Qinghai, Ningxia, Xinjiang, and Xinjiang Production and Construction Corps
.

The procurement of the 11-province alliance in Guangdong involved 276 drugs, including blood products, basic infusion agents and other exclusive and non-exclusive products.
Growth hormone products were also included, making it a pioneer in the inclusion of biological products in provincial procurement
.
(see the end of the article for a detailed list)

With the development of the inter-provincial procurement alliance with volume, its procurement model has become relatively mature.
The procurement varieties have expanded from chemical drugs to the fields of Chinese patent medicines and biological drugs, and many valuable rule innovations have also been explored
.
For example, the catalogue of goods purchased by the Chongqing Eight-Province Alliance is divided into two types: commonly used medicines and shortage medicines, and the rules are distinguished according to different types of purchases.
It is considered to be an early exploration of special volume purchases
.

According to the incomplete statistics of Yilianzhao Procurement Network, the number of inter-provincial centralized procurement alliances has grown to 16.
Judging from the number of purchases, the volume-based procurement has included local centralized procurement in the past three years.
The average number of centralized procurement varieties in each province has reached 50
.

At the above-mentioned briefing, Chen Jinfu, deputy director of the National Medical Insurance Administration, said that the centralized procurement of inter-provincial alliances is still the main body of procurement with volume
.

This year, the state will guide local governments to make progress based on clinical needs, focusing on large varieties and common diseases, to check and fill gaps, and strive to achieve more than 100 provincial-level centralized collection varieties in each province
.

Chen Jinfu explained that the original centralized procurement of small-scale medicines at the prefecture and county levels was relatively unstandardized, with inconsistent local rules, and even some illegitimate transfer of benefits
.
However, due to the relatively complex clinical drug use, it is not realistic to recruit and purchase all from the national level
.
Compared with the above two schemes, the inter-provincial procurement alliance with volume has unified rules, centralized procurement, and can reduce the burden on enterprises.
Therefore, the provincial alliance is still the main body of centralized procurement
.

Attached:

Centralized procurement of 132 Chinese patent medicines in 6 provinces of Guangdong

List of 276 Drug Collections in 11 Provinces of Guangdong